Enterocolitis Clostridium Difficile Recurrent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Enterocolitis Clostridium Difficile Recurrent trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Enterocolitis Clostridium Difficile Recurrent trials you may qualify forThis trial will be initiated to explore whether RBX2660 (REBYOTA®) could be suitable for administration by the practice of colonoscopy. More specifically, the p…
This study evaluates the efficacy of prophylaxis with oral vancomycin for preventing recurrent Clostridium difficile Infection (CDI) in patients who have experi…
This is a prospective, multicenter, open-label Phase 3 study of a microbiota suspension of intestinal microbes. Patients who have had at least one recurrence of…